Perla Giles, a rising senior majoring in molecular microbiology, and David Lee, a rising senior majoring in chemistry, both ...

Adults hospitalized for RSV face higher odds of cardiac complications than those with COVID-19 or influenza, especially in ...

Nirsevimab implementation in Catalonia, Spain, reduced emergency department visits and hospital admissions for bronchiolitis ...

The first bacteria our bodies meet – in the hours after we're born – could protect us from dangerous infections, UK ...

The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

A group of bat viruses closely related to the deadly Middle East respiratory syndrome coronavirus (MERS-CoV) could be one ...

A substantial burden of hospitalizations for PIV-associated ARI was observed among pediatric patients in the United States.

A single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections (The drug ...

Federal health officials issued new guidance last week on who should have the COVID-19 vaccine, and it no longer includes ...

CNW/ -- (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to provide a summary of current operating ...

When an RSV vaccine became available for use during pregnancy, it offered a natural experiment between various countries to ...

RSV seasons ended earlier than usual in 2022-23 and 2023-24, and typical human hMPV circulation patterns have returned since the COVID-19 pandemic.